Sarepta therapeutics announces call for applications for the 7th annual route 79, the duchenne scholarship program

Cambridge, mass.--(business wire)--sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced the official opening of route 79, the duchenne scholarship program for the 2024-2025 academic year. academic scholarships of up to $5,000 will be awarded to as many as 20 individuals living with duchenne muscular dystrophy and five siblings of individuals living with duchenne. applications will be accepted until monday, may 13, 2024, at 11:59 p.
SRPT Ratings Summary
SRPT Quant Ranking